Vanguard Capital Management’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.8M Buy
3,273,451
+314,768
+11% +$1.31M ﹤0.01% 2519
2026
Q2
$12.2M Buy
2,958,683
+508,696
+21% +$2.37M ﹤0.01% 2707
2026
Q1
$11.1M Buy
+2,449,987
New +$8.48M ﹤0.01% 2675

Other funds holding IRD

Vanguard Capital Management's IRD Position: Q3 2026 in Review

Vanguard Capital Management increased its Opus Genetics (IRD) stake by 11% in Q3 2026, buying an estimated $1.31M and bringing the position to 3,273,451 shares worth $15.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2519.

Vanguard Capital Management first reported a position in IRD in Q1 2026 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • Vanguard Capital Management held 3,273,451 shares of Opus Genetics worth $15.8M as of Q3 2026.
  • Vanguard Capital Management bought 314,768 Opus Genetics shares in Q3 2026, an estimated $1.31M.
  • Opus Genetics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2519 holding.
  • Vanguard Capital Management first reported a position in Opus Genetics in Q1 2026 and has held it in 3 quarters since.
  • 114 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.